Insider Transactions in Q3 2021 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
James C Mullen CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,478
+33.79%
|
-
|
|
Aug 09
2021
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
287
-0.42%
|
$16,359
$57.17 P/Share
|
|
Aug 09
2021
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-8.0%
|
$150,000
$60.0 P/Share
|
|
Aug 09
2021
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.41%
|
$75,000
$30.65 P/Share
|